Stories about research and scientific development at Mount Sinai
Can GLP-1 Receptor Agonists Help Preserve Brain Volume?
For those living with multiple sclerosis (MS), GLP-1 receptor agonists (GLP-1 RA) might represent a new mechanism for combating disease progression. Though initially developed for diabetes treatment, GLP-1 agents have become famous for inducing weight loss. However,...
Sam Horng, MD, PhD: Expanding the MS Center Purview
Sam Horng, MD, PhD, came to The Corinne Goldsmith Dickinson Center for Multiple Sclerosis in 2015 on a three-year combined clinical and research fellowship after completing his neurology residency at the Icahn School of Medicine at Mount Sinai. His work exemplifies...
Riding the New Wave of AI in Health Care
The health care industry has overwhelmingly embraced artificial intelligence (AI) technology in all aspects—clinical, academic, administrative, and more—and with the breakneck speed of progress in this area, it’s little wonder the field is seeing an outpouring of...
Public Health Research Day 2026 Showcases Student Innovation, Collaboration, and Career Inspiration at Mount Sinai
Public Health Research Day, hosted by the Graduate Program in Public Health, recently celebrated student research from the master’s programs in the Department of Public Health at the Icahn School of Medicine at Mount Sinai. The event, held Thursday, May 21, began with...
Mount Sinai Nurse Scientists: At the Forefront
The landscape of research conducted by nurses is evolving, and Mount Sinai’s Center for Nursing Research and Innovation (CNRI) is leading the charge. In June 2025, the Health System hosted the nation’s first conference on the role of the clinically based nurse...
Addressing the Cognition Concerns of Multiple Sclerosis Patients
Multiple sclerosis (MS) patients often worry that the disease will diminish their ability to think and remember, along with their motor skills. Sarah Levy, PhD, Assistant Professor of Neurology at the Icahn School of Medicine at Mount Sinai, is working to address...
Getting a Head Start With AI at the Icahn School of Medicine at Mount Sinai
Most first-year medical students spend their time mastering anatomy, memorizing biochemical pathways, and adjusting to the pace of clinical training. For Alvira Tyagi, that first year coincided with an opportunity to understand the rapid transformation in how patients seek health information with AI tools. “I did not expect to be involved in AI-driven health care research so early as a student,” says Ms. Tyagi. Read about how she began working at the intersection of AI and health care, and the importance for students to be familiar with this rapidly evolving field.
How An Interest in Cardiothoracic Surgery Is Shaping Caroline Tavolacci’s Path as a Surgeon-Scientist at Mount Sinai
Sooyun Caroline Tavolacci, MD, MSCR, is a third-year PhD student in the Clinical Research Program at the Icahn School of Medicine at Mount Sinai and a surgeon-scientist in training. Her dissertation research focuses on heart transplantation outcomes, specifically...
Mount Sinai AIHH Grand Rounds: A Thoughtful Way to Adopt AI in Health Care
Health care systems across the country have been increasingly using artificial intelligence (AI) systems to assist and augment what clinicians and researchers can achieve. Isaac Kohane, MD, PhD, Chair of the Department of Biomedical Informatics, Harvard Medical School, was invited as keynote speaker of Mount Sinai’s Windreich Department of AI and Human Health (AIHH) monthly seminar series AIHH Grand Rounds, and he spoke about the transformative potential of AI and how to guide its growth ethically.